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1. Introduction 
It is widely recognized that vascular function is modulated by the endocrine system. So it is 
known that hormones as aldosterone, renin-angiotensin II system, thyroids hormones, 
oxitocine, ghrelin, vasopressine, etc exert action on the vascular tone (Axelband et al., 2011; 
Nguyen & Touyz, 2011; Szmydynger-Chodobska et al., 2011; Tesauro et al., 2010;). Regarding 
sex hormones, epidemiological studies have demonstrated that there is a gender difference 
in the morbidity associated with hypertension and that there is an increased prevalence of 
cardiovascular diseases in postmenopausal women (Leung et al., 2007; Teede, 2007). 
Simultaneously, androgens had been associated with an increased risk of cardiovascular 
disease, but recent studies have explored protective effects of androgens in males (Jones, 
2010; Traish and Kypreos, 2011). For example, it has been demonstrated that men with 
coronary artery disease have decreased levels of testosterone, which were conversely 
correlated to the degree of coronary artery narrowing (Saad et al., 2008). Likewise, lower 
testosterone, predicted incident stroke and transient ischemic attack in older men (Braga-
Basaria, 2006). In general terms, it seems to be demonstrated that men with cardiovascular 
disease had lower levels of testosterone, and what is more important, new emerging 
evidence points to androgen deficiency more likely to be associated with cardiovascular 
diseases than gender per se (Traish & Kypreos, 2011). Testosterone deficiency alters 
carbohydrate, lipid and protein metabolism, this contributing to oxidative stress, endothelial 
dysfunction and increased production of pro-inflammatory factors, promoting alterations 
on vascular function. Among the alterations induced by testosterone deficiency are the loss 
of muscle mass and strength, increasing visceral fat mass, reduced libido, erectile 
dysfunction, increased osteoporosis, lethargy, lack of energy, and changes in mood. In 
addition, testosterone deficiency has been associated with increased risk of metabolic 
syndrome, type 2 diabetes, obesity, insulin resistance and atherosclerosis (Jones & Saad, 
2009; Kapoor et al., 2005). 
Most of results obtained about that effects have been obtained from patients with prostate 
cancer subjected to androgen deprivation therapy. This therapy improves cancer related 
symptoms and quality of life (Bain, 2010), but shows side effects as sexual dysfunction, 
decreased lean body mass, decreased quality of life, osteoporosis, and detrimental changes 
in metabolic status (Basaria & Dobs, 2001; Chodak et al., 2002; Smith et al., 2002). Increased 
insulin levels and insulin resistance and increased prevalence of fasting hyperglycemia and 
hypertriglyceridemia have also been observed in men with prostate cancer treated with 
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androgen deprivation therapy (Braga-Bassaria et al., 2006; Keating et al., 2006). This type of 
therapy provides an invaluable method to correlate vascular alteration and sex hormone 
status. However, at mechanistic level the animal models are of valuable interest. In this 
sense our research group has been focused on analyzing the effects produced by the loss of 
gonadal function on vascular reactivity, as well as some of the underlaying mechanisms.   
Vascular tone is regulated by several mechanisms in which nitric oxide (NO) plays an 
important role. NO is formed through several NO synthases (NOS), i.e., endothelial NOS 
(eNOS), inducible (iNOS), and neuronal (nNOS). Independently from the source of NO, one of 
the major downstream events occurring after NO release is an increase in cGMP formation 
through soluble guanylate cyclase stimulation, and the subsequent activation of cGMP-
dependent protein kinase (PKG) (Murad, 1997). PKG contributes to reduce the intracellular 
calcium concentration through a wide spectrum of PKG substrates, leading to vasodilation 
(Lincoln et al., 2001; Munzel et al., 2003). In addition, NO (Bolotina et al., 1994) and cGMP 
(Ferrer et al., 1995) can induce membrane hyperpolarization and subsequent relaxation.  
Concerning NO, and independently from the NO-activated signalling pathway, it is important 
to take into account that vascular function of endothelial NO depends on its bioavailability, 
which is determined by the rate of NO production and by its scavenging by superoxide anion. 
Therefore, the elimination of superoxide anion within the vessel wall is fundamental and it is 
performed by superoxide dismutases (SODs) (Wolin, 2002). It is well understood that 
alterations of different steps along the NO pathway determine its effect on the vascular tone.  
Vascular tone is also regulated by prostanoids originated by arachidonic acid metabolism 
through the cyclooxygenase (COX) pathway (Henrion et al., 1997). One of the best studied 
prostanoids is thromboxane A2 (TXA2) which has been implicated as mediator in diseases 
such as myocardial infarction and hypertension (FitzGerald et al., 1987). Additionally, the 
role of COX derivatives other than TXA2, such as prostaglandin (PG) F2α and PGE2, or PGI2 
which can induce a vasoconstrictor or vasodilator response is the subject of numerous 
studies (Blanco-Rivero et al., 2005; Félétou & Vanhoutte, 2006) since they could also 
participate in vascular dysfunction. 
On the other hand, proteins kinases are important regulators of different cell signalling 
pathways. Among different proteins kinases, PKC merits special attention since it is able to 
regulate the activity of different enzymes such as NOS and COX-2 (Kim et al., 2008; 
Shanmugam et al., 2004). In turn, PKC can be activated by different reactive oxygen species.  
At this point, it is important to note that sex hormones possesses antioxidant properties, and 
the loss of gonadal function can induce oxidative stress and, in turn triggers modulatory 
actions in different cell signalling pathways that are working simultaneously to ensure the 
optimal response of the vessel to different stimuli. 
For this, this chapter will review how the loss of gonadal function modifies the release and 
function of different mediators, such as reactive oxygen species, nitric oxide and 
prostanoids, and their functional involvement in the reactivity of aorta and mesenteric 
artery of the male rats. Future studies in the research field of androgens on cell signaling 
pathways will be commented, since they will be of important interest to implement 
therapeutic strategies that could improve vascular function.  
2. Androgens and nitric oxide 
The functional role of NO in vascular tone regulation has been widely reported (Furchgott & 
Zawadzki, 1980; Toda & Okamura, 2003; Vanhoutte 1996). NO is formed through several 
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NO synthases (NOS), i.e, endothelial NOS (eNOS), inducible (iNOS) and neuronal (nNOS) 
(Förstermann et al., 1991). Most of the studies about the effects of androgens on vascular 
function have been focused on analyzing the interaction between androgens and endothelial 
NO (Tep-areenan et al., 20043; Jones et al., 2004). More specifically, most studies have been 
focused on analyzing the effects of androgenic derivatives on different aspects of the NO 
system, such us eNOS expression, NO release or NO vasodilator effect (Ceballos et al., 1999; 
Hutchison et al., 1997; Teoh et al., 2000). However, few studies exist about the specific effect 
of endogenous male sex hormones on these aspects referred to endothelial or neuronal NO 
when they are simultaneously studied. Our data were obtained from aorta and mesenteric 
artery from intact and orchidectomized male Sprague-Dawley rats (6 months old), and seem 
not to be related to haemodynamic changes, since orchidectomy did not modify blood 
pressure (137 + 5.8 mm Hg in control rats and of 145 + 6.2 mm Hg in orchidectomized rats; p 
> 0.05). Moreover, the results on vascular function would have to be androgen-related, as 
confirmed by the decreased testosterone levels (control: 2404 + 323 pg/mL; 
orchidectomized: 220 + 49 pg/mL; n = 6; p < 0.001).  
The reported effects of androgens on NO release are contradictory. Testosterone impairs 
relaxation and worsens endothelial dysfunction in male rabbits (Hutchison et al., 1997). 
However, it has also been reported that testosterone or its derivatives increase eNOS (Liu & 
Dillon, 2002; Weiner et al., 1994) and nNOS activity in the central nervous system of guinea 
pig (Weiner et al., 1994) and mouse (Scordalakes et al., 2002). Nevertheless, to our 
knowledge, we showed first evidence on the effect of endogenous male sex hormones on the 
nNOS/eNOS expression and nNOS-/eNOS-derived NO release in vascular tissues (Martin 
et al., 2005; Blanco-Rivero et al., 2007). 
2.1 Neuronal nitric oxide 
The analysis of the expression of nNOS, by Western blot, showed that it was higher in 
segments from control rats than from orchidectomized rats (Martín et al., 2005). The NO 
release was quantified by measuring nitrite production and also the fluorescence emitted by 
DAF-2, and the results showed that electrical field stimulation EFS-induced NO release was 
similar in segments from both control and orchidectomized rats. The measured NO release 
seems to come from nerve endings, since preincubation with tetrodotoxin abolished the nitrite 
release in endothelial-denuded segments from both groups of rats. This result indicates that 
male sex hormones apparently do not modulate nNOS-derived NO release, in contrast to our 
observations with female sex hormones in which we found that the loss of these hormones 
provoked by ovariectomy increased nNOS-derived NO release (Minoves et al., 2002). 
To study the involvement of neuronal or endothelial NO on vasomotor responses, EFS 
induced contractile responses in endothelium-denuded mesenteric segments were analyzed 
by using vascular reactivity technique (Nielsen & Owman, 1971). The contractile response 
induced by EFS were practically abolished by tetrodotoxin and markedly reduced by 
phentolamine, the respective blockers for nerve impulse propagation and α-adrenoceptors 
in arteries from both control and orchidectomized rats. Therefore, these responses appear to 
be mediated by noradrenaline (NA) release from adrenergic nerve terminals and the 
subsequent activation of α-adrenoceptors in both experimental hormonal conditions, as has 
been described in other rat strains (Ferrer et al., 2000; 2001).  
The present results show that vasoconstrictor response to KCl and exogenous NA are 
diminished in segments from orchidectomized male rats, which is in agreement with most 
studies demonstrating that testosterone treatment enhanced the action of several contractile 
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agents (Baker et al., 1978; Calderone et al., 2002; Greenberg et al, 1974). However, the 
responses induced by EFS was similar in both groups of rats Fig. 1 which would suggest 
that EFS increased the release of a vasoconstrictor factor, that could be the NA release from 
adrenergic endings in segments from orchidectomized animals. 
Concerning this point, most studies have been performed in the central nervous system and, 
conflicting results exist. Thus, a decrease (Guan &Dluzen, 1991; Holmquist et al., 1994), an 
increase (Shan & Dluzen, 2002; Siddiqui & Shah, 1997) and no modification (Agostini et al., 
1981; Chen et al., 1999) of NA release have been reported in orchidectomized male animals. 
In a later study we demonstrated that the NA release was not modified by orchidectomy 
(Blanco-Rivero et al., 2006). 
 
 
Fig. 1. Contractile response induced by cumulative concentration-response curves to 
noradrenaline (NA) and by frequency-response curves in denuded mesenteric arteries from 
control and orchidectomized rats. Results (means + SEM) are expressed in milligram. 
Number of animals: 25-30. * p<0.01 compared with control rats (from Martín et al., 2005). 
Since sex hormone modulation of the calcitonin gene related peptide (CGRP) system has 
been described (Sun et al., 2001), and that the CGRP, the essential neurotransmitter in 
sensory nerves (Kawasaki et al., 1988), had been proposed to play a role in vascular tone 
regulation, the participation of sensory innervation in the vasomotor response to EFS was 
assessed by the use of capsaicin, which selectively depletes the sensory nerves of the 
neurotransmitter (Li & Duckles, 1992). Capsaicin did not have a significant effect on the 
vasomotor response to either EFS or exogenous NA in mesenteric arteries from control and 
orchidectomized rats (data not shown), indicating that sensory innervation does not 
modulate the vasomotor response to EFS in our experimental conditions. Sun et al., (2001) 
analyzed how orchidectomy modulates CGRP release, while we analyzed the functional 
involvement of the sensory innervation in the response to EFS without separately studying 
CGRP release and/or response.   
The NOS inhibitor L-NAME increased the vasoconstrictor response to EFS in segments from 
both control and orchidectomized rats. The fact that the endothelium was removed and that 
AMT, an inhibitor of iNOS (Ferrer et al., 2000; Ishikawa & Quock, 2003; Tracey et al., 1995), 
did not modify the response induced by EFS in segments from both rat groups, reinforced 
the neuronal origin for the NO release.  
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Fig. 2. Effect of L-NAME on the frequency-response curves performed in mesenteric arteries 
from control and orqchidectomized rats. Results are expressed as a percentage of a previous 
tone with 75 mM KCl. n, number of animals; *p<0.05; **p<0.01 compared with control rats 
(from Martín et al., 2005).  
The greater response to EFS in the presence of L-NAME in segments from orchidectomized 
animals compared with the response obtained in segments from control rats Fig. 2 indicated 
differences in steps downstream  from neuronal NO release, that will be considered later. 
The reported effects of androgens on NO release are contradictory. Testosterone impairs 
relaxation and worsens endothelial dysfunction in male rabbits (Hutchison et al., 1997). 
However, it has also been reported that testosterone or its derivatives increase eNOS (Liu & 
Dillon, 2002; Weiner et al., 1994) and nNOS activity in the central nervous system of guinea 
pig (Weiner et al., 1994) and mouse (Scordalakes et al., 2002). Nevertheless, to our 
knowledge, there is no experimental evidence on the effect of male sex hormones on the 
nNOS expression and nNOS-derived NO release in vascular tissues. Therefore, we analysed 
the expression of nNOS by western blot, and found it was higher in segments from control 
rats than from orchidectomized rats. We also quantified the NO release induced by EFS in 
segments from both groups of rats by measuring nitrite production and the fluorescence 
emitted by DAF-2, and the results showed that the EFS-induced NO release was similar in 
segments from both control and orchidectomized rats. 
2.2 Endothelial nitric oxide 
The eNOS expression in aorta and mesenteric artery showed that not was modified by 
orchidectomy (Blanco-Rivero et al., 2007; Martorell et al., 2008), in contrast to that observed 
in endothelial-denuded mesenteric artery (Martín et al., 2005), which indicates that 
endogenous male sex hormones act in a different manner depending on the target protein. 
Additionally, these results also indicate that effects induced by endogenous hormones are 
quite different from those induced by exogenous hormones, since it has been reported that 
androgenic derivatives can increase (Simoncini et al., 2003), decrease (Chatrath et al., 2003) or 
not affect (McNeill et al., 1999) eNOS expression. 
Regarding eNOS activity, androgen-induced increase (Liu & Dillon, 2002; Simoncini et al., 
2003) and decrease (Mukherjee et al., 2001) have both been reported. Others researchers have 
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demonstrated that androgens increased (Orshal & Khalil, 2004; Wynne & Khalil, 2003) and 
decreased (Ba et al., 2001; Gonzales et al., 2004) the vasodilator effect of endothelial NO. In our 
experimental rat model, we have found that the release of endothelial NO was not modified 
by orchidectomy, either in mesenteric artery (Blanco-Rivero et al., 2007) or aorta (Blanco-Rivero 
et al., 2006). However, orchidectomy reduced the endothelium-dependent vasodilator response 
induced by Acetylcholine (Ach) in mesenteric artery while increased in rat aorta (Fig. 3).  
 
 
Fig. 3. Concentration-response curve to acetylcholine (ACh) in mesenteric artery and aortic 
segments from control and orchidectomized rats. Results are expressed as a percentage of a 
previous tone with noradrenaline. Number of animals is indicated in parentheses (from 
Blanco-Rivero et al., 2007; Ferrer et al., 1999). 
These results could indicate that orchidectomy, depending on the vessel, may alter the 
sensitivity to NO and/or the release of factors other than NO, that will be revised in the next 
sections.   
3. Androgens and production of reactive oxygen species 
Reactive oxygen species are involved in metabolising NO (Gryglewski et al. 1986, Ferrer et al. 
2000, 2001) and it has been reported that can induce oxidative processes associated with 
cardiovascular disorders (Harrison 1994; Munzel et al., 1997). Among all the reactive oxygen 
species, superoxide anion plays a critical role since it is a source of many other reactive oxygen 
intermediates (Beckman & Koppenol, 1996). Therefore, both production and removal of 
superoxide anion are important contributors to the maintenance of appropriated levels of this 
oxygen species. Since several studies have demonstrated androgens antioxidants properties of 
androgens (Békési et al., 2000; Yorek et al., 2002), the effect of the orchidectomy on the 
production of superoxide anion was analyzed, by measuring the lucigenin chemiluminescence 
(control =117 + 43 U/mg/min, n= 5; orchidectomized= 546 + 58 U/mg/min, n= 5; p < 0.001). 
A similar result was obtained with acetylcholine-induced superoxide anion in aortas from the 
same animals (control: 34.7 +5.6 U/mg/ min, n= 4; orchidectomized: 132.8 + 3.2, n= 4; p< 
0.001). These results agree with previous studies showing the antioxidants properties of 
androgens (Békési et al., 2000; Yorek et al., 2002). The elimination of superoxide anion within 
the vessels is fundamental since this oxygen specie can reduce the NO bioavailability.  
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Within the vessel wall, SODs transform superoxide anion to hydrogen peroxide (Oury et al., 
1996, Price et al., 2000, Muzykantov, 2001). Although three SOD isoforms have been identified: 
cytosolic Cu/ZnSOD, mitochondrial MnSOD, and extracellular ecSOD –which is also Cu/Zn-
dependent (Strehlow et al., 2003), we have focused on analyzing the participation of 
Cu/ZnSOD since it is the predominant isoform in peripheral vessels (Namgaladze et al., 2005), 
and this enzyme therefore plays a crucial role in the pathogenesis of vascular dysfunction 
(Wolin, 2002). We analyzed the expression and activity of SODs because there was no 
information about modulation of these enzymes by endogenous male sex hormones. We 
found that both the expression and activity of Cu/ZnSOD were increased in aortic segments 
from orchidectomized rats (Fig. 4). These results were in line with other studies that described 
an increased expression and/or activity of SOD in cardiovascular pathologies, in which 
superoxide anion overproduction exists (Kobayashi et al., 2002, Tanaka et al., 2005). 
 
 
Fig. 4. Representative western blot for Cu/ZnSOD and) α-actin expression and SOD activity 
in aortic segments from control (C) and from orchidectomized (Cx) rats (from Blanco-Rivero 
et al., 2006).  
In addition, these results indicated that the increases in both expression and activity of 
Cu/ZnSOD could be a compensatory mechanism to eliminate the elevated superoxide 
anion formation induced by orchidectomy in male rats. On the other hand, additional 
mechanisms may exist to try to maintain vasodilator function. One of these mechanisms 
could be the activation of calcium-dependent potassium channels by superoxide anion 
(Ferrer et al., 1999). In that report, we confirmed that the calcium dependent potassium 
channels (KCa) activation was specifically induced by superoxide anion, since the NO 
synthesis was inhibited. 
However, the vascular response depends on the vascular bed analyzed. For example, in 
mesenteric artery from orchidectomized rats, the vascular ROS-induced relaxation was due 
to the production of peroxynitrite and hydrogen peroxide H2O2. The increased formation of 
peroxynitrite in arteries from orchidectomized rats was studied by immunohistochemical 
localization and was reinforced by functional analysis on vasodilator response induced by 
sodium nitroprusside (SNP): 
The presence of SOD increased the response to SNP in segments from orchidectomized rats 
which could be mediated through the decreased peroxynitrite formation by removing 
superoxide anion, and the simultaneous increased of H2O2 formation, which exert 
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vasodilator action (Martín et al., 2005; Rubanyi & Vanhoutte, 1986; Wei et al., 1996). The 
simultaneous incubation of arteries with SOD and catalase reversed the vasodilator 
response to SNP, indicating that the H2O2 synthesized in the presence of SOD, would 
participate in that vasodilator effect, when the formation of peroxynitrite is inhibited (Fig. 5). 
 
 
Fig. 5. Effect of orchidectomy, and effect of superoxide dismutase (SOD) and SOD plus 
catalase on the concentration-response curves to sodium nitroprusside (SNP) in mesenteric 
artery segments from orchidectomized rats. Results are expressed as a percentage of the 
inhibition of contraction induced by noradrenaline. Number of animals is indicated in 
parentheses. *p<0.01 compared with control (from Martín et al., 2005). 
At this point, it has been discussed that the loss of male sex hormones did not modify: 
(1) the nNOS-derived NO release induced by EFS although it did increase the NO 
metabolism through superoxide anion and peroxynitrite generation; however, the functional 
role of the nNOS-derived NO release was more pronounced in arteries from 
orchidectomized animals, due to products generated from the NO metabolism, such as 
peroxynitrite and hydrogen peroxide, that seem to be able to compensate for the loss of NO 
bioavailability, probably through their direct vasodilator effect,  
(2) the eNOS-derived NO release induced by Ach in both aorta and mesenteric artery; 
however the functional role of the endothelial NO release seem to be different in both 
arteries: Ach-induced relaxation is totally dependent of NO because the Ach-induced 
relaxation is inhibited when the synthesis of NO is blocked (Blanco-Rivero et al., 2007), as 
occur in aorta from control  rats, while in aorta from orchidectomized rats important 
relaxation exist even after NO synthesis was blocked (Ferrer et al., 1999). 
These differences could be due to the existence of regulatory mechanisms turned on by the 
loss of gonadal function that include, at least, prostanoids production. 
4. Androgens and prostanoids 
Endothelial cells also release vasoconstrictor and vasodilator prostanoids, originated from 
the arachidonic acid metabolism through the cyclooxygenase (COX) pathway, to regulate 
vascular tone (Blanco-Rivero et al., 2005; Feletou & Vanhoutte, 2006; Henrion et al., 1997). 
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Two major isoforms of COX exist: COX-1 is expressed constitutively and is usually 
abundant in all animal and human endothelial cells, whereas endothelial COX-2 is induced 
mainly during inflammatory responses in nearly all animals. Depending on the vessel 
studied and the agonist used to activate cells, different prostanoids can be released and 
contribute to vasomotor response depending on the prostanoid receptor that result 
activated. Among all the prostanoids, one of the most studied is thromboxane A2 (TXA2), 
which has been implicated as a mediator in diseases such as myocardial infarction, 
hypertension, stroke and bronchial asthma (FitzGerald et al., 1987; Narumiya et al., 1999; 
Noll& Luscher, 1998). However, little information is available on the effect of androgens on 
vascular effects of endogenous TXA2. Thus, orchidectomy has been reported to either 
decrease (Gonzales et al., 2005) or not modify (Blanco-Rivero et al., 2006) TXA2 synthase 
expression. Likewise, the contractile effect induced by the TXA2 mimetic, U-46619, was not 
modified by orchidectomy in mesenteric (Blanco-Rivero et al., 2006) and cerebral (Gonzales 
et al., 2005)  rat arteries.   
On the other hand, the role of COX-derivates, other than TXA2, such as prostaglandin (PG) 
I2, PGF2α and PGE2, which can act as vasoconstrictors under certain pathological conditions, 
is the objective of numerous studies (Félétou et al., 2010; Gluais et al., 2005; Rapoport & 
Williams, 1996). However, to the best of our knowledge studies analyzing the effect of 
endogenous male sex hormones in the involvement of these prostanoids in vascular 
function were lacking, and therefore this was one of our objectives. As above commented, 
we have previously demonstrated that EFS induced similar contractile response (Fig.1) in 
mesenteric arteries from control and orchidectomized rats, responses that appear to be 
mediated by NA release from adrenergic nerve terminals and the subsequent activation of 
α-adrenoceptors (Martín et al., 2005); in addition, we found that the contractile response to 
exogenous NA was decreased by orchidectomy, suggesting the EFS could increase NA 
release in arteries from orchidectomized rats; however, we later demonstrated the EFS-
induced NA release was not modified by orchidectomy (Blanco-Rivero et al., 2006) which 
indicated that other vasoconstrictor factors could be released when the artery was 
electrically stimulated. We observed that the EFS induced a greater TXA2 formation in 
arteries from orchidectomized than control rats, which was in line with other reports 
showing increased TXA2 release after activation of muscarinic (Blanco-Rivero et al., 2007) or 
α2-adrenoceptors (Blanco-Rivero et al., 2006), and it confirmed the endothelial and smooth 
muscle cells as sources of TXA2 production. The increased TXA2 release could be the 
contractile factor that was released when the artery is electrically stimulated, and explains 
the non modification of the EFS-induced response in arteries from control and 
orchidectomized rats, in spite of the fact that the NA response was diminished in arteries 
from the latter animals. 
It has been previously reported that prostanoids other than TXA2, i.e. prostaglandin (PG) I2 
increased neuronal NO release (Ferrer et al., 2004) and taking into account that in our 
experimental conditions the main neurotransmitters involved in that response elicited by 
EFS were NO and NA, we investigated the regulation of the NA and NO release and 
function by TXA2. We observed that in arteries from control rats, the TXA2 synthesis 
inhibition, with furegrelate, increased the neuronal NO release, which was in line with  
reports describing an inhibitory effect of TXA2 on inducible (Yamada et al., 2003) and 
endothelial (Miyamoto et al., 2007) NO release. The vasodilator response induced by the NO 
donor, sodium nitroprusside was also increased by furegrelate. Concerning the effects of 
TXA2 on NA release, inhibition (Nishihara et al., 2000) or non-modification (Rump & 
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Schollmeyer, 1989) have been reported. In our experimental model, the inhibition of TXA2 
synthesis did not modify either NA release or its vasomotor effect, which indicated that 
endogenous TXA2 did not alter the function of sympathetic innervations on arteries from 
control rats. By contrast, in arteries from orchidectomized rats, endogenous TXA2 did not 
regulate either the release/function of neuronal NO or NA. The results obtained in 
mesenteric arteries from control animals explain the decreased EFS-induced response in the 
presence of furegrelate; however, did not explain the unaltered EFS-induced response in 
arteries from orchidectomized rats, since to remove a constrictor substance a decreased in 
EFS-induced vasoconstriction would be expected. Since cross-talk between TXA2 and PGI2 
has been reported (Cheng et al., 2002; Martorell et al., 2008) and joint increases in PGI2 and 
TXA2 synthesis have been shown in pathological conditions (Caughey et al., 2001; 
FitzGerald, 1991), the effect of TXA2 on PGI2 production was analyzed, as well as, its 
dependence of the hormonal status. We observed that the inhibition of endogenous 
synthesis of TXA2 did not modify the release of PGI2 in arteries from control rats, while it 
did greatly increase PGI2 release in arteries from orchidectomized rats, which could work as 
a contractile factor after activation of TXA2 receptors. Taking together these results, the loss 
of gonadal function in male rats increased the non-endothelial TXA2 release in mesenteric 
arteries, and regulates the EFS-induced response through different mechanisms.  
As previously commented, orchidectomy increased the TXA2 release in endothelial-intact 
mesenteric arteries (Blanco-Rivero et al., 2006; 2007). Similar effect was also observed in 
aorta segments from comparable animals (Martorell et al., 2008), however, in this case the 
relaxation to ACh was increased. Based on this result, the level of expression of COX-2 as 
well as the production of prostanoids derived from COX-2 other than TXA2 was 
investigated. We found that COX-2 expression, in contrast to observations in mesenteric 
artery (Blanco-Rivero et al., 2006), was increased in aortas from orchidectomized rats 
indicating that endogenous male sex hormones act differently depending on the specific 
vessel. Our results also show that, in aorta from orchidectomized rats, COX-2 derivatives 
could also be increased and play a role in the regulation of vascular function. To test this 
hypothesis, we analyzed the effect of the COX-2 inhibitor NS-398 on the ACh-induced 
response. In contrast to our assumptions, we found that NS-398 did not modify the ACh-
induced relaxation in either group of rats, apparently indicating the lack of participation of 
COX-2 derived products in the ACh response, probably due to the equilibrium between the 
inhibition of prostanoids formation and phosphodiesterase inhibition (Klein et al., 2007), 
which allowed us to speculate that the contribution of different prostanoids to the 
vasodilator response mediated by ACh could be regulated by endogenous male sex 
hormones. 
Once we had established that orchidectomy increased TXA2 release, we analyzed the 
possible role of this prostanoid in the response to ACh by analyzing the effect of the TXA2 
synthase inhibitor, furegrelate, and the TP receptor antagonist, SQ29,548, on the vasodilator 
response to ACh. We observed that neither substance had any effect on the ACh-induced 
response in arteries from control animals, indicating that TXA2 did not participate in that 
response, in agreement with reports in other rat strains (Gluais et al., 2005; Rapoport & 
Williams, 1996). However, in arteries from orchidectomized rats, furegrelate enhanced the 
vasodilator response to ACh, showing a functional involvement of TXA2. The fact that the 
contractile response to the TXA2 mimetic U-46619 was similar in arteries from control and 
orchidectomized rats demonstrated that sensitivity to TXA2 is not modified by 
orchidectomy, which agrees with reports in cerebral (Gonzales et al., 2005) and mesenteric 
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(Blanco-Rivero et al., 2006) arteries; additionally, it also shows that differences in the TXA2 
involvement in the ACh-response are due to increased synthesis rather than increased 
sensitivity to TXA2. However, the incubation with SQ29,548 did not affect the ACh-induced 
relaxation, which seems to contradict the results obtained with furegrelate. However, since 
interactions among different prostanoids have been reported (Bachschmid et al., 2005; Cheng 
et al., 2002), it is possible to hypothesize that when TXA2 synthesis is inhibited, the 
production of other prostanoids, which counterbalance the TXA2 effect, could be increased. 
Therefore, we investigated the effect of inhibiting PGI2 synthesis (with TCP) on the ACh-
induced response, observing that it decreased the vasodilator response to ACh to a greater 
extent in arteries from orchidectomized than in those of control rats, which would indicate a 
greater involvement of this vasodilator prostanoid in the former arteries. Therefore, the 
release and vasomotor effect of PGI2 was investigated. The ACh-induced PGI2 release was 
increased in arteries from orchidectomized rats, probably due to the superoxide anion 
overproduction observed in aortas from orchidectomized rats (Blanco-Rivero et al., 2006), 
supporting the concept of redox regulation of vascular prostanoid synthesis proposed by 
Bachschmid et al. (2005). Moreover, the increased production of PGI2 is in line with that 
reported in human syndromes involving platelet activation in which PGI2 biosynthesis is 
elevated along with TXA2 (Caughey et al., 2001; FitzGerald, 1991). It is known that PGI2 can 
induce both vasodilation, through activation of prostacyclin receptors (IP) and thereby 
increasing cyclic-AMP, and vasoconstriction through activation of TP receptors (Blanco-
Rivero et al., 2005). In the present study, we found that exogenous PGI2 induced relaxation 
in rat aorta, and that it was decreased in arteries from orchidectomized rats, which could be 
due to differences in the expression of IP receptors rather than differences in cell signalling 
operating after receptor activation; we have observed that the relaxation induced by the 
activator of adenylate cyclase, forskolin, was similar in arteries from control and 
orchidectomized rats (unpublished data).  
Since considerable evidence exists for cross-talk between the TXA2 and PGI2 systems (Cheng 
et al., 2002), we analyzed the functional effect of inhibiting the synthesis of both prostanoids. 
We observed that co-incubation of arteries with TCP plus furegrelate, or TCP plus SQ29,548,  
reversed the decreased response to ACh caused by TCP in arteries from control rats, 
showing the existence of a balance between TXA2 and PGI2 in these arteries. However, in 
arteries from orchidectomized rats, the co-incubation with TCP plus furegrelate did not 
modify the decreased ACh response caused by TCP, indicating the participation of 
prostanoids other than PGI2 and TXA2 that could induce contraction. Moreover, these 
prostanoids would activate TP receptors since co-incubation with TCP and SQ29,548 
completely reversed the decrease in the ACh response induced by TCP.  
Among COX-2 derivatives, other than TXA2 and PGI2, that can activate TP receptors, PGE2 
is the most plausible candidate (Gluais et al., 2005; Blanco-Rivero et al., 2007) since the ACh-
induced PGF2α production and its vasoconstrictor effect were both very limited. Therefore, 
we investigated the ACh-induced PGE2 release, as well as its vasoconstrictor effect. We 
found that both ACh-induced PGE2 production and PGE2-induced vasoconstrictor response 
were greater in arteries from orchidectomized than in those of control rats. Consequently, 
the ACh-induced PGE2 release, under inhibited synthesis of TXA2 and PGI2, was analyzed. 
We found the ACh-induced PGE2 production further increased, probably as a consequence 
of increased PGH2 production and subsequent transformation into PGE2 (Frein et al., 2005); 
and, what is more important, the PGE2 increase was more pronounced in arteries from 
orchidectomized than in those of control rats.  
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Fig. 6. Scheme showing the effect of orchidectomy on different mechanisms involved in the 
ACh-induced relaxation (see text for explanation). 
This finding confirms our hypothesis that when the synthesis of PGI2 and TXA2 was inhibited, 
the release of PGE2 was increased in arteries from orchidectomized rats, but raises the question 
as to why the PGE2 produced in the presence of TCP plus furegrelate did not affect the ACh-
induced relaxation in arteries from control animals. The possible explanation could be that the 
PGE2 release was not sufficient to induce a vasomotor effect and/or the PGE2-induced 
contraction in arteries from control rats was diminished as a consequence of different 
expression of EP receptor subtypes. By itself, this finding is of physiological relevance, since 
PGE2 release and the vasoconstrictor effect are both increased in orchidectomized animals. In 
summary, in rat aorta orchidectomy enhances COX-2 expression, and induces an imbalance in 
the production and function of vasodilator and vasoconstrictor prostanoids, in such a way that 
the vasoconstrictor prostanoids predominate in the latter group. Additionally, we have 
previously reported a decreased NO bioavailability in aorta from orchidectomized rats 
(Blanco-Rivero et al., 2006) that would also counteract the vasodilator response to ACh. 
However, despite these findings, the vasodilator response to ACh is increased in aorta from 
orchidectomized rats, probably as a consequence of compensatory mechanisms, such as the 
activation of KCa channels by superoxide anion, the formation of which is increased in 
orchidectomized rats (Ferrer et al., 1999) (Fig. 6). 
5. Androgens and NO release, oxidative stress and protein kinase C 
interactions 
The results described above point to that orchidectomy increases the oxidative stress 
through superoxide anion formation, but in contrast to that expected, without modifying the 
NO release. What is the mechanism underlying this effect?. 
In several types of vascular diseases, protein kinase C (PKC) activation is involved in the 
induction of oxidative stress through the increased expression and activity of NADPH 
oxidase and the eNOS uncoupling (Hadi & Swaidi, 2007; Vanhoutte, 2001). But increased 
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of PKC activity by different reactive oxygen species has been also reported (Balafanova et 
al., 2002; Bapat et al., 2001; Oeckler & Wolin, 2000). PKC is a ubiquitous enzyme that was 
originally described as calcium-activated, phospholipid-dependent protein kinase. 
Molecular cloning and biochemical analysis have revealed a family of PKC subspecies 
with closely related structures (Newton, 1995; Nishizuka, 1992). The activity of these 
proteins is critical for signal transduction of a wide range of biological responses (Chen, 
2003; Nishizuka, 1984). The pathways through PKC exerts its vascular effects include 
actions on ion channels, cytoskeleton and cell adhesion proteins, transcription factors, 
other kinases and other proteins (Spitaler & Cantrell, 2004; Ward et al., 2004). The 
participation of PKC in vascular smooth muscle contraction is well established (Khalil & 
van Breemen, 1988; Salamanca & Khalil, 2005); in addition, different investigations have 
also reveal that PKC can phosphorylate nNOS in the central nervous system leading to an 
increase (Nakane et al., 1991; Okada, 1995) or a decrease (Bredt et al., 1992; Dawson et al., 
1993) in neuronal NO production.  
On the other hand, influence of gender on PKC activity and expression had been studied 
(Kanashiro & Khalil, 2001). In that work, the authors observed a gender-specific reduction in 
vascular smooth muscle reactivity in female rats with intact gonadal function compared 
with males, that was associated with a reduction in the expression and activity of different 
α-, δ-, and ζ-PKC isoforms; they also proposed that gender-specific differences in vascular 
reactivity and PKC activity were possible related  to endogenous estrogen. However, little 
information is available on the specific effect of endogenous male sex hormones on PKC 
activity in vascular tissues.  
As described in the section corresponding to neuronal NO release, we observed that the 
neuronal NO release was not modified by orchidectomy although the nNOS expression was 
diminished, which indicated that nNOS activity could be increased; regarding regulation of 
nNOS by male sex hormones both increase (Simoncini et al., 2003; Weiner et al., 1994) or 
decrease (Reynoso et al., 2002; Singh et al., 2000) have been reported. Since in our 
experimental model, orchidectomy induced an increased oxidative stress, we analyzed the 
possible differences in PKC activity as well as its involvement in neuronal NO release.  
We observed that orchidectomy increased PKC activity in rat mesenteric arteries (Blanco-
Rivero et al., 2005), in contrast to the results obtained in aorta from Wistar-Kyoto rats 
(Kanashiro & Khalil, 2001); this discrepancy could be due to differences in the artery 
analyzed, since it has been described different enzyme properties and function in the same 
blood vessels from different species and in different vessels from the same species (Liou & 
Morgan, 1994; Kanashiro & Khalil, 1988;Khalil etal., 1992). However, the fact that PKC was 
increased by orchidectomy is not totally surprising, since orchidectomy increased the 
formation of superoxide anion and peroxynitrite that has been described to act in cell 
signalling pathways, for instance, increased PKC activity (Balafanova et al., 2002; Bapat et al., 
2001; Oeckler & Wolin, 2000). 
The regulatory effect of PKC on nNOS activity in arteries from the orchidectomized and the 
control animals was analyzed by using DAF-2 as fluorescence probe to measure the 
modification in basal and EFS-induced NO release. The results showed that the PKC 
activator PDBu (Abdel-Latif, 1986; Nishizuka, 1984) induced a greater increase in EFS-
induced NO release in arteries from control than from orchidectomized animals, while the 
PKC inhibitor, calphostin C (Kobayashi et al., 1989), induced a stronger decrease in arteries 
from the control than the orchidectomized animals (Fig. 7).  
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Fig. 7. Effect of PDBu, calphostin, Gö-6976 or PKCζ-PI on the basal-and EFS-induced NO 
release in mesenteric arteries from control and orchidectomized rats. Results are expressed as 
arbitrary units (AU). Number of animals=4-7. *p<0.05, **p<0.01 vs the respective basal NO 
release from control rats; #p<0.05 vs the respective basal NO release from orchidectomized rats 
(from Blanco-Rivero et al., 2005). 
These results indicate that PKC is involved in nNOS activation in arteries from both control 
and orchidectomized rats. Because the degree of PKC activation is already greater in arteries 
from orchidectomized rats, PDBu and calphostin C showed less ability to respectively 
increase or diminish NO release in arteries from orchidectomized than from control rats. 
Conventional and novel PKC isoforms are dependent on dyacylglycerol (DAG) (Ward et al., 
2004) and, since we use the pharmacological mimetic of DAG, PDBu, we stimulate both 
isoforms. Although selective inhibitors for these isoforms do not exist (Davies et al., 2000) it 
has been reported that certain compounds, such as the indolocarbazole Gö6976, are partially 
selective for conventional over the novel and atypical isoforms (Martiny-Baron et al., 1993; 
Ward et al., 2004). Consequently, we tested the effect of this inhibitor on nNOS activity, and 
observed that a concentration of 0.1 µM Gö6976 inhibited the EFS-induced neuronal NO 
release in arteries from control arteries while it did not affect the neuronal NO release in 
arteries from orchidectomized rats. A higher Gö6976 concentration (1 µM) was used but it 
only decreased the EFS-induced NO release in arteries from orchidectomized rats. All these 
results support the assumption that nNOS seems to be much more activated by PKC, and 
probably the conventional PKC isoforms, in arteries from the orchidectomized than from the 
control rats. 
Since the atypical PKC ζ isoform has been described in vascular smooth muscle as 
modulating vascular responses to different agents (Cogolludo et al., 2003; De Witt et al., 
2001), the effect of this isoform on nNOS activity was analyzed. We found that PKCζ-PI 
decreased EFS-induced NO release to a similar extent in arteries from control and 
orchidectomized animals. This result indicates that PKC ζ isoform involvement in the 
regulation of neuronal NO release occurs and that this involvement is not modulated by 
endogenous male sex hormones. 
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Regarding endothelial NO release, it has been previously described that orchidectomy did 
not modify the Ach-stimulated endothelial NO release, despite the increased production of 
superoxide anion. Based on the results obtained about PKC regulation of nNOS activity, the 
action of PKC activation or inhibition on eNOS activity was also investigated in arteries 
from orchidectomized and control animals. The results obtained showed that neither the 
PKC activator, PDBu (Nishizuka, 1984), nor the PKC inhibitor, calphostin C (Kobayashi et al. 
1989), modified ACh-induced NO release in arteries from control animals. In contrast, in 
arteries from orchidectomized rats, PKC activation increased the basal and the ACh-
induced NO release while PKC inhibition more strongly decreased both basal and ACh-
induced NO release (Fig. 8).  
 
 
Fig. 8. Effect of PDBu, calphostin, Gö-6976 or PKCζ-PI on the basal - (white columns) and 
Ach - (dashed columns) induced NO release in mesenteric arteries from control and 
orchidectomized rats. Results are expressed as arbitrary units (AU). Number of animals=8. 
*p<0.05 vs the respective basal NO release; #p<0.05 vs basal NO release in non treated 
arteries (from Blanco-Rivero et al., 2007). 
These results indicate that PKC participates in eNOS activity only in arteries from 
orchidectomized rats, and also seem to indicate that PKC apparently did not regulate eNOS 
activity in arteries from control animals, which contrast with the results reported with nNOS 
(Blanco-Rivero et al., 2005) in which we observed an nNOS activity modulation by PKC. In 
this respect, it is possible to speculate that very subtle differences could exist in the 
modulation of NOS isoforms. In this regard, it is important to keep in mind that regulatory 
mechanisms other than PKC could be working on eNOS, including different redox 
conditions (Polytarchou & Papadimitriou, 2005), phosphatases activity (Fleming et al., 2001) 
and/or other kinases (Ferrer et al., 2004) that, in their turn, regulate the intracellular 
environment and function. Additionally, since the pharmacological mimic of dyacylglycerol, 
PDBu, stimulate conventional and novel PKC isoforms (Ward et al., 2004) and since 
calphostin C is a non specific PKC inhibitor, we tested the effect of the PKC inhibitor 
Gö6976, which is partially selective for conventional over novel and atypical PKC isoforms 
(Martiny-Baron et al., 1993, Ward et al., 2004). We observed that this inhibitor also decreased 
basal and ACh-induced NO in arteries from orchidectomized rats, indicating the 
involvement of the conventional PKC isoforms in endothelial NO regulation. Since the 
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atypical PKCζ isoform has been reported to modulate vascular responses (Damron et al., 
1998, De Witt et al., 2001, Cogolludo et al., 2003) and neuronal NO release (Blanco-Rivero et 
al., 2005), we also tested the possible involvement of this isoform in endothelial NO release. 
The fact that PKCζ-PI decreased the basal and ACh-induced NO release showed the 
participation of this isoform. Moreover, since the three PKC inhibitors that we used, 
calphostin C, Gö6976 and PKCζ-PI, diminished both basal and ACh-induced NO release, it 
seems that eNOS, like nNOS (Blanco-Rivero et al., 2005), would have already been activated 
by PKC in arteries from orchidectomized rats. 
These results show that PKC activity is enhanced  in mesenteric arteries from 
orchidectomized rats, and this increase would be responsible for the higher nNOS and 
eNOS activity. 
6. Conclusions 
Orchidectomy alters different cell signalling pathways that are involved in vascular tone 
regulation. Orchidectomy increases: (i) the formation of superoxide anion and peroxynitrite; 
(ii) the activity of PKC; and (iii) the expression of COX-2, the production of prostanoids 
derived from COX-2, as well as their vasoconstrictor effect. These aspects seem to be 
physiologically relevant, since the balance between vasodilator/vasoconstrictor prostanoids 
is lost in favour of vasoconstrictor substances in arteries from orchidectomized rats. This 
situation could indicate a disadvantage in cardiovascular function in the absence of male sex 
hormones, thereby suggesting that testosterone has a beneficial influence on the vasculature. 
However, in the animals used in our study (6 months old) several compensatory 
mechanisms are working: reactive oxygen species are able to induce relaxation; PKC 
positively regulates nNOS and eNOS activity ensuring the maintenance of NO release; the 
activity and expression of SOD are increased in an attempt to compensate for the increased 
superoxide anion production. This intriguing information makes it essential to perform 
studies in vascular function taking into account different cell signalling pathways that are 
working simultaneously. Future studies in the research field of androgens on cell signaling 
pathways are needed, since they will be of important interest to implement therapeutic 
strategies that could improve vascular function. 
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